Article Details

Tonabersat by Inflammx Therapeutics for Diabetic Nephropathy: Likelihood of Approval

Retrieved on: 2024-01-04 18:39:35

Tags for this article:

Click the tags to see associated articles and topics

Tonabersat by Inflammx Therapeutics for Diabetic Nephropathy: Likelihood of Approval. View article details on hiswai:

Excerpt

Premium Insights. From. The gold standard of business intelligence. Blending expert knowledge with cutting-edge technology, GlobalData's unrivalled ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo